Skip to main navigation
Veracyte, Inc.
{'Menu'|t}
Tests
Diseases areas
Cancer
Thyroid cancer
Prostate cancer
Lung cancer
Breast cancer
Bladder cancer
Other
Interstitial lung disease
Products
Thyroid Cancer
Afirma Genomic Sequencing Classifier
Prostate Cancer
Decipher Prostate Genomic Classifier
Breast Cancer
Prosigna Breast Cancer Assay
Interstitial Lung Disease
Envisia Genomic Classifier
Bladder Cancer
Decipher Bladder Genomic Classifier
Instructions for use
Quality certificates
Safety data sheet
Pipeline
Portfolio and test expansion
Enabling global access
MRD technology
Publications
Partner Services
Biopharma services
IVD services
Company
About us
Who we are
Leadership
Corporate recognition
Contact
News & Events
News
Press releases
In the news
Events
Careers
Culture
Job Openings
Investors
Overview
Press Releases
Events & Presentations
Financials
SEC filings
Quarterly results
Annual reports
Stock information
Analyst coverage
Governance
Governance overview
Board of directors
Comittee composition
Leadership
ESG information
Investor Resources
Investor FAQs
Information request
Email alerts
Tests
Diseases areas
Products
Pipeline
Publications
Cancer
Thyroid cancer
Prostate cancer
Lung cancer
Breast cancer
Bladder cancer
Other
Interstitial lung disease
Portfolio and test expansion
Thyroid Cancer
Afirma Genomic Sequencing Classifier
Prostate Cancer
Decipher Prostate Genomic Classifier
Breast Cancer
Prosigna Breast Cancer Assay
Interstitial Lung Disease
Envisia Genomic Classifier
Bladder Cancer
Decipher Bladder Genomic Classifier
Instructions for use
Quality certificates
Safety data sheet
Enabling global access
Portfolio and test expansion
Enabling global access
MRD technology
Who we are
Partner Services
Biopharma services
IVD services
Company
About us
Contact
Who we are
Leadership
Corporate recognition
Culture
News & Events
News
Events
Press releases
In the news
Who we are
Careers
Culture
Job Openings
Investors
Overview
Press Releases
Events & Presentations
Financials
Governance
Investor Resources
SEC filings
Quarterly results
Annual reports
Stock information
Analyst coverage
ESG information
Governance overview
Board of directors
Committee composition
Leadership
ESG information
Annual reports
Investor FAQs
Information request
Email alerts
Annual reports
ESG information
2023 ESG Report
27.7 MB
Facebook
Twitter
LinkedIn